KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Retained Earnings (2017 - 2025)

Novartis Ag (NVS) has disclosed Retained Earnings for 9 consecutive years, with $45.4 billion as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 4.87% to $45.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.4 billion through Dec 2025, up 4.87% year-over-year, with the annual reading at $45.4 billion for FY2025, 4.87% up from the prior year.
  • Retained Earnings hit $45.4 billion in Q4 2025 for Novartis Ag, up from $43.3 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $66.8 billion in Q4 2021 to a low of $43.3 billion in Q4 2024.
  • Historically, Retained Earnings has averaged $52.0 billion across 5 years, with a median of $45.9 billion in 2023.
  • Biggest five-year swings in Retained Earnings: increased 19.85% in 2021 and later decreased 21.63% in 2023.
  • Year by year, Retained Earnings stood at $66.8 billion in 2021, then fell by 12.36% to $58.5 billion in 2022, then fell by 21.63% to $45.9 billion in 2023, then fell by 5.62% to $43.3 billion in 2024, then rose by 4.87% to $45.4 billion in 2025.
  • Business Quant data shows Retained Earnings for NVS at $45.4 billion in Q4 2025, $43.3 billion in Q4 2024, and $45.9 billion in Q4 2023.